LANXESS Aktiengesellschaft (ETR:LXS) Trading Down 1.1% - Here's What Happened

Key Points

• Shares fell 1.1% mid-day to €18.06 (intraday low €17.48) on heavy trading of ~640,817 shares, a ~105% increase versus average volume.
• The company has a market cap of $1.64 billion, a negative P/E (-1.89) and a high debt-to-equity (72.47), with 50‑day/200‑day SMAs at €16.97/€17.84.
• LANXESS is a specialty chemicals firm operating three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates.

LANXESS Aktiengesellschaft (ETR:LXS - )'s stock price dropped 1.1% during mid-day trading on Monday . The company traded as low as €17.48 and last traded at €18.06. Approximately 640,817 shares changed hands during trading, an increase of 105% from the average daily volume of 312,027 shares. The stock had previously closed at €18.26.

LANXESS Aktiengesellschaft Stock Performance

The company has a current ratio of 1.67, a quick ratio of 0.57 and a debt-to-equity ratio of 72.47. The company has a market cap of $1.64 billion, a P/E ratio of -1.89, a PEG ratio of 1.12 and a beta of 1.34. The business's 50 day simple moving average is €16.97 and its 200 day simple moving average is €17.84.

About LANXESS Aktiengesellschaft

LANXESS Aktiengesellschaft, together with its subsidiaries, operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The Consumer Protection segment provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.